Refine search

Date
Tumour Site
Topics
Congress

669 results for ""

Using the Microbiome to augment Immunotherapy response

Using the Microbiome to augment Immunotherapy response

The intriguing possibility that altering the microbiome might offer a way of augmenting response to immunotherapy is one of the pioneering new treatment options being explored in oncology.

TAT 2020 Honorary Award recipient Lillian L. Siu, Professor at the University of Toronto and Medical Oncologist at the Princess Margaret Cancer Centre, Toronto, explains the latest progress being made in using ‘bugs as drugs’.

General session-ESMO 2019

Off-label therapies: what is their future?

Many studies presented at the Congress hint at promising treatments for rare sarcomas but access to effective treatments remains a challenge 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.